{
    "clinical_study": {
        "@rank": "158076", 
        "acronym": "SMSaude", 
        "arm_group": [
            {
                "arm_group_label": "ART no SMS reminders", 
                "arm_group_type": "Active Comparator", 
                "description": "control group"
            }, 
            {
                "arm_group_label": "PMTCT no SMS reminders", 
                "arm_group_type": "Active Comparator", 
                "description": "control group"
            }, 
            {
                "arm_group_label": "SMS reminders to PMTCT cohort", 
                "arm_group_type": "Experimental", 
                "description": "experimental group"
            }, 
            {
                "arm_group_label": "SMS reminders to ART cohort", 
                "arm_group_type": "Experimental", 
                "description": "experimental group"
            }
        ], 
        "brief_summary": {
            "textblock": "Mobile phone SMS are increasingly used to promote positive health behaviour with an aim to\n      improve health outcomes. However, robust data on the efficacy of SMS on health seeking\n      behaviour and patient outcomes in resource-limited settings is sparse. The SMSaude study\n      aims to assess whether regular SMS-reminders improve retention on antiretroviral therapy\n      (ART) and prevention of mother to child transmission of HIV (PMTCT) programmes in\n      Mozambique."
        }, 
        "brief_title": "Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "HIV-positive", 
        "condition_browse": {
            "mesh_term": "HIV Seropositivity"
        }, 
        "detailed_description": {
            "textblock": "SMSa\u00fade is a multisite randomised clinical trial of HIV-infected adults on ART and\n      HIV-infected pregnant women in six clinics in Maputo Province, Mozambique. Eligibility\n      criteria include: currently residing in the province; no plans to move for 12+ months; have\n      own cell-phone; literate; 8-28 weeks pregnant (PMTCT cohort); on first line ART and on ART\n      for >15 days (ART cohort). Patients were interviewed for eligibility, and then randomized\n      (1:1). SMS reminders are sent to the intervention group using software that picks up the\n      patient's next appointment from the electronic patient database. Primary outcomes tested\n      were improved retention in ART care and uptake of all PMTCT services."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  On ART for >15 days (for ART only)\n\n          -  Live in province and plan to stay for 12+ months\n\n          -  Have cell phone\n\n          -  Literate\n\n        For PMTCT (in addition to above criteria):\n\n        - pregnant between 8-28 weeks\n\n        Exclusion Criteria:\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "1352", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01910493", 
            "org_study_id": "SMSaude01"
        }, 
        "intervention": {
            "arm_group_label": [
                "ART no SMS reminders", 
                "PMTCT no SMS reminders", 
                "SMS reminders to PMTCT cohort", 
                "SMS reminders to ART cohort"
            ], 
            "description": "Intervention participants only will be sent text messages to their phones. The content of text messages will have a maximum of 160 characters and not mention HIV and will state the dates for the forthcoming consultations, visits to the pharmacy, lab results, time to take medication and reminders for patients who miss appointments.", 
            "intervention_name": "SMS reminders", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "mhealth", 
            "mobile health", 
            "SMS", 
            "SMS reminders", 
            "ART retention in care", 
            "PMTCT", 
            "PMTCT cascade", 
            "retention in care"
        ], 
        "lastchanged_date": "July 25, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Matola, Xinavane, Machava and Namaacha", 
                    "country": "Mozambique", 
                    "state": "Maputo"
                }, 
                "name": "6 Health Facilities"
            }
        }, 
        "location_countries": {
            "country": "Mozambique"
        }, 
        "number_of_arms": "4", 
        "official_title": "Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique: A Randomized Control Trial", 
        "overall_official": {
            "affiliation": "University of Eduardo Mondlane", 
            "last_name": "Cesar de Palha, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "University of Eduardo Mondlane: Mozambique", 
                "Ministry of Health: Mozambique"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Retention in ART care", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01910493"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Retention in PMTCT care", 
            "safety_issue": "No", 
            "time_frame": "until 8 weeks post partum"
        }, 
        "source": "Absolute Return for Kids", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Vodacom", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "United States Agency for International Development (USAID)", 
                    "agency_class": "U.S. Fed"
                }, 
                {
                    "agency": "Department for International Development, United Kingdom", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Absolute Return for Kids", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}